中国医院用药评价与分析
中國醫院用藥評價與分析
중국의원용약평개여분석
EVALUATION AND ANAL YSIS OF DRUG-USE IN HOSPITALS OF CHINA
2014年
11期
993-995
,共3页
砂附汤%慢性萎缩性胃炎%多潘立酮
砂附湯%慢性萎縮性胃炎%多潘立酮
사부탕%만성위축성위염%다반립동
Shafu soup%Atrophic gastritis%Domperidone tablets
目的：观察砂附汤治疗慢性萎缩性胃炎的临床疗效和安全性。方法：将108例慢性萎缩性胃炎患者，按随机数字表法分为治疗组和对照组，其中治疗组患者58例，给予中药汤剂砂附汤治疗，每日1副；对照组患者50例，给予多潘立酮治疗，1次10 mg，1日3次，餐前服用。2组患者均服药2个月，观察治疗前后2组患者的临床症状、胃泌素等指标的变化情况。结果：治疗组患者的临床症状、胃泌素均有明显改善，均优于对照组，2组差异有统计学意义（ P＜0.05）；2组患者均未出现不良反应。结论：砂附汤治疗慢性萎缩性胃炎有良好疗效，且安全性好。
目的：觀察砂附湯治療慢性萎縮性胃炎的臨床療效和安全性。方法：將108例慢性萎縮性胃炎患者，按隨機數字錶法分為治療組和對照組，其中治療組患者58例，給予中藥湯劑砂附湯治療，每日1副；對照組患者50例，給予多潘立酮治療，1次10 mg，1日3次，餐前服用。2組患者均服藥2箇月，觀察治療前後2組患者的臨床癥狀、胃泌素等指標的變化情況。結果：治療組患者的臨床癥狀、胃泌素均有明顯改善，均優于對照組，2組差異有統計學意義（ P＜0.05）；2組患者均未齣現不良反應。結論：砂附湯治療慢性萎縮性胃炎有良好療效，且安全性好。
목적：관찰사부탕치료만성위축성위염적림상료효화안전성。방법：장108례만성위축성위염환자，안수궤수자표법분위치료조화대조조，기중치료조환자58례，급여중약탕제사부탕치료，매일1부；대조조환자50례，급여다반립동치료，1차10 mg，1일3차，찬전복용。2조환자균복약2개월，관찰치료전후2조환자적림상증상、위비소등지표적변화정황。결과：치료조환자적림상증상、위비소균유명현개선，균우우대조조，2조차이유통계학의의（ P＜0.05）；2조환자균미출현불량반응。결론：사부탕치료만성위축성위염유량호료효，차안전성호。
OBJECTIVE:To evaluate the clinical efficacy and safety of Shafu soup for atrophic gastritis. METHODS:A total of 108 patients with atrophic gastritis were randomized to either treatment group ( 50 cases ) or control group(58 cases) .The treatment group received Shafu soup and the control group received Domperidone tablets (10 mg each time preprandial t.i.d) for two months.The changes in clinical symptoms and gastrin level of the two groups were followed.RESULTS:The improvement in clinical symptoms and gastrin level in the patients treated with Shafu soup were significantly better than in the control group ( P<0.05 ) , and two group of patients without adverse reactions.CONCLUSIONS:Shafu soup is safe and effective for atrophic gastritis.
